Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales von Allen, Rachel, PhD, Bryden, Peter, MSc, Grotzinger, Kelly M., PhD, Stapelkamp, Ceilidh, MPH, Woods, Bethan, BA, MSc

Volltext

Adjusting for the Confounding Effects of Treatment Switching—The BREAK‐3 Trial: Dabrafenib Versus Dacarbazine von Latimer, Nicholas R., Abrams, Keith R., Amonkar, Mayur M., Stapelkamp, Ceilidh, Swann, R. Suzanne

Volltext

Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab von Bullement, Ash, D'Angelo, Sandra P., Amin, Amerah, Stapelkamp, Ceilidh, Willis, Anna, Lilley, Cameron, Hatswell, Anthony, Bharmal, Murtuza

Volltext

Abstract CT330: Adjusting for confounding effects of treatment crossover in a randomized phase 2 study of dabrafenib plus trametinib in BRAF V600+ metastatic melanoma von Latimer, Nicholas, Amonkar, Mayur, Stapelkamp, Ceilidh, Sun, Peng

Volltext

Cost and economic burden of adverse events associated with metastatic melanoma treatments in five countries von Vouk, Katja, Benter, Ursula, Amonkar, Mayur M., Marocco, Alessia, Stapelkamp, Ceilidh, Pfersch, Sylvie, Benjamin, Laure

Volltext

Adjusting for confounding effects of treatment switching in a randomized phase II study of dabrafenib plus trametinib in BRAF V600+ metastatic melanoma von Latimer, Nicholas R, Amonkar, Mayur M, Stapelkamp, Ceilidh, Sun, Peng

Volltext

Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study) von Grange, Florent, Mohr, Peter, Harries, Mark, Ehness, Rainer, Benjamin, Laure, Siakpere, Obukohwo, Barth, Janina, Stapelkamp, Ceilidh, Pfersch, Sylvie, McLeod, Lori D, Kaye, James A, Wolowacz, Sorrel, Kontoudis, Ilias

Volltext

Adjusting for treatment crossover in the BREAK-3 metastatic melanoma trial for dabrafenib: Preliminary analysis von Latimer, Nicholas, Abrams, Keith R., Amonkar, Mayur, Stapelkamp, Ceilidh, Swann, R. Suzanne

Volltext

Survival outcomes and treatment costs for patients with double‐refractory chronic lymphocytic leukaemia (DR‐CLL) von Bloor, Adrian, De Cock, Erwin, Hatswell, Anthony J, Wasiak, Radek, Elvidge, Jamie, Stapelkamp, Ceilidh, Hadjivassileva, Tsveta, Haiderali, Amin, Delgado, Julio

Volltext

Predictors of early death in female patients with breast cancer in the UK: a cohort study von Stapelkamp, Ceilidh, Holmberg, Lars, Tataru, Daniela, Møller, Henrik, Robinson, David

Volltext

Predictors of early death in female patients with breast cancer in the UK: a cohort study von Stapelkamp, Ceilidh, Holmberg, Lars, Tataru, Daniela, Møller, Henrik, Robinson, David

Volltext